CardioInsight Technologies

CardioInsight Technologies

Develops the electrocardiographic mapping technology that non-invasively generates images of the heart’s electrical activity. Learn more

Launch date
Market cap
-
Enterprise valuation
AUD93—139m (Dealroom.co estimates Nov 2013.)
Cleveland Ohio (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

N/A

Spinout

$300k

Series A

$6.0m

Series B
N/A

$4.0m

Early VC

$50.0k

Series B
N/A

$1.7m

Debt
N/A

$7.5m

Early VC

$7.5m

Series C

$15.0m

Series C

$93.0m

Acquisition
Total FundingAUD62.4m

Recent News about CardioInsight Technologies

Edit
More about CardioInsight Technologiesinfo icon
Edit

CardioInsight operates in the medical technology sector, specializing in advanced cardiac mapping solutions. The company serves healthcare providers, including hospitals and cardiology clinics, by offering non-invasive, real-time 3D mapping technology to diagnose and treat arrhythmias. This technology allows for precise localization of cardiac electrical activity, improving the accuracy of diagnoses and the effectiveness of treatments. CardioInsight's business model revolves around the sale and leasing of its proprietary mapping systems, as well as providing ongoing support and maintenance services. Revenue is generated through the initial sale or lease agreements, as well as recurring income from service contracts and consumables. The market for CardioInsight's products includes both domestic and international healthcare institutions, with a focus on regions with advanced healthcare infrastructure. The company aims to enhance patient outcomes and streamline clinical workflows, thereby reducing overall healthcare costs.

Keywords: cardiac mapping, arrhythmia diagnosis, non-invasive, real-time 3D mapping, healthcare providers, cardiology clinics, medical technology, patient outcomes, clinical workflows, healthcare costs.